This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Philip Michael Cocks and His Aripiprazole Particle Patent.
Introduction
Philip Michael Cocks is an inventor associated with Huddersfield, Great Britain. His patent work concerns a process for preparing crystalline aripiprazole monohydrate, a pharmaceutical compound. The available information identifies Bristol-Myers Squibb Company as his employer.
Latest Patents
Cocks is associated with 1 patent, titled “Process of Making Aripiprazole Particles.” The invention describes preparing crystalline aripiprazole monohydrate using solution-enhanced dispersion by supercritical fluid. Water is introduced into a stream of supercritical fluid, which is then mixed with a stream containing aripiprazole and a solvent. This process enables the substantially simultaneous dispersion and extraction of aripiprazole from the mixture.
Career Highlights
The patent reflects work on a specialized method for producing crystalline pharmaceutical particles. The supplied information connects Cocks’s professional career with Bristol-Myers Squibb Company.
Collaborations
Cocks’s identified coworkers include Simon Crawford Bristow and David R. Worthen. The available details do not specify their roles in the patent or the extent of their collaboration.
Conclusion
Philip Michael Cocks’s recorded patent contribution focuses on a supercritical-fluid process for preparing crystalline aripiprazole monohydrate, linking his inventive work to pharmaceutical manufacturing.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile